Skip to content

A Complex Contraception Registry

A Complex Contraception Registry - UC Family Planning Collaborative Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02219269
Enrollment
97
Registered
2014-08-18
Start date
2014-06-30
Completion date
2015-06-30
Last updated
2018-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Cancer, Cardiovascular Disease, Diabetes, Epilepsy, Lupus Erythematosus, Systemic, Migraine, Neurological Disorders, Organ or Tissue Transplant; Complications, Other Hematologic Conditions, Other Venous Embolism and Thrombosis

Keywords

contraception, family planning, complex medical conditions

Brief summary

The investigators will conduct a prospective observational cohort study to investigate factors that influence contraceptive method utilization among women with medical conditions. The investigators will also investigate how women with medical conditions access to contraception and family planning fellowship trained specialist. After the baseline questionnaire, there be a 3 month and 6 month follow up questionnaire to investigate continuation and satisfaction with the contraceptive method. This study is unique because it will allow us to explore doing collaborative family planning research at the multiple UC medical campuses.

Detailed description

Many women with complex medical conditions who do not desire pregnancy do not receive contraception counseling from their primary or subspecialty care clinicians, and often they are not using contraception. This is an important deficiency as many have conditions that could worsen with pregnancy or for whom pregnancy can be complicated by the medical condition. Thus it is important for women with chronic disease to only become pregnant if they intend to do so. The United States Medical Eligibility Criteria for Contraceptive Use (USMEC), released in 2010, has greatly enhanced the ability of clinicians to counsel patient with complex medical conditions about their contraceptive options. It summarizes the safety of specific contraceptives when used on women with medical conditions. However, little is known about the contraceptive care of these women. We do not know if the availability of the USMEC has translated into evidence-based contraceptive counseling for these women. Further, little is known about their understanding of the interaction between their disease and pregnancy, their past experience and knowledge about contraception, and their contraceptive decision-making, satisfaction and continuation. The purpose of the Complex Contraception Registry to is to recruit a cohort of women with complex medical conditions who are seen in contraception referral practices run by family planning fellowship trained physicians. We will assess their past experiences and baseline knowledge, their post-counseling experiences and choice of contraception, and their long-term satisfaction with and continuation of contraception. A multi-center registry is necessary because individual institutions see relatively few women with rare diseases such as a history of transplant surgery. The UC Family Planning Collaborative will facilitate recruitment of participants from the 5 UC medical campuses and will oversee their follow-up for one year. Specific Aim include (1.) To investigate what factors influence contraceptive method utilization among women with complex medical conditions and their perceived risk of unintended pregnancy (2) To investigate how women with complex medical conditions access family planning fellowship trained specialist for contraception counseling and (3.) To assess satisfaction and continuation of contraceptive methods among women with complex medical conditions.

Interventions

None listed

Sponsors

University of California, Los Angeles
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
University of California, Irvine
CollaboratorOTHER
University of California, Davis
CollaboratorOTHER
University of California, San Diego
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Ethnic Background: No limitation, will include minorities 2. Sexually Active with men 3. Diagnosis with at least one of the following conditions * Diabetes and other endocrine disorders * Cardiovascular Disease, such as Ischemic Heart Disease, Valvular disease, hypertension or pulmonary hypertension * Epilepsy, Migraine, and other neurologic disorders * History of or current cancer * History of or planning Bariatric Surgery * History of or planning Solid Organ Transplant * Systematic Lupus Erythematous and other rheumatologic conditions * History of or current Venous Thrombosis Embolism * Other Medical Conditions (such as Sickle Cell Disease or Cystic Fibrosis)

Exclusion criteria

1. Pregnant at time of recruitment 2. History of hysterectomy, bilateral oophorectomy, or sterilization procedure 3. Unable to provide informed consent 4. Attempting to become pregnant at time of recruitment 5. Not sexually active with men 6. No active telephone number or email for follow up Women who are pregnant will be excluded from this study. However, no pregnancy testing will be conducted; pregnancy status will be based on self-reporting by subjects.

Design outcomes

Primary

MeasureTime frameDescription
Contraceptive method continuation and satisfaction6 monthQuestionnaire is used to report continued use and satisfaction with multiple choice answer: very satisfied, somewhat satisfied, dissatisfied. Questionnaires will be administered at 3 months and 6 months after recruitment.

Secondary

MeasureTime frameDescription
History of unintended pregnancy6 monthsMeasured with questionnaire at baseline, 3 months, and 6 months
Change in Medical Condition6 monthsMeasured with questionnaire at 3 months and 6 months
History of contraceptive methods used6 monthsMeasured with questionnaire at baseline
If Contraception is Accessed in post-partum or post-abortion setting6 monthsMeasured with questionnaire at baseline, 3 months, and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026